StockData
Healthpeak Properties, Inc. logo

Healthpeak Properties, Inc. (DOC) KPIs and segments

DOCNYSEReal Estate Investment TrustsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/3016% above fair value
$19.84−0.14 (-0.70%)

Close on Nov 16, 2026Market cap $13.68BP/E 56.7Yield 6.15%

KPI & bộ phận

Chỉ số vận hành và bộ phận làm nên hoạt động của Healthpeak Properties · năm tài chính kết thúc ngày 31 tháng 12

Nhìn nhanh KPI của Healthpeak Properties: 40 chỉ số vận hành, trong đó có Total Portfolio Properties, Outpatient Medical — Total Rentable Capacity và Lab — Total Rentable Capacity, lấy từ 426 tài liệu nguồn, cùng doanh thu theo bộ phận, sản phẩm và khu vực từ hồ sơ SEC. Mỗi số đều dẫn tới tài liệu gốc. Tất cả chỉ số hiện cả bảng; Cốt lõi chỉ giữ bộ phận và KPI nổi bật. Bảng bộ phận còn có cách xem lũy kế 12 tháng.

Biểu đồ đang trống. Tick vào ô cạnh bất kỳ chỉ số nào ở bảng dưới để vẽ — tick nhiều chỉ số để so sánh trên cùng một biểu đồ.

Bộ phận, KPI nổi bật và mọi chỉ số vận hành từ hồ sơ, thông cáo kết quả và bản trình bày.

Thêm vào biểu đồChỉ số
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Outpatient Medical Buildings($M)
327320321318333238
Outpatient medical($M)
311318315314
Senior housing($M)
216200149149
Lab($M)
216213213209218226214224223
CCRC($M)
150149149146143141139136
Kỳ báo cáo trước đây (báo cáo lần cuối 2024)1
Kỳ báo cáo trước đây (báo cáo lần cuối 2024)4
Kỳ báo cáo trước đây (báo cáo lần cuối 2024)4
Kỳ báo cáo trước đây (báo cáo lần cuối 2023)1
Kỳ báo cáo trước đây (báo cáo lần cuối 2025)3
Total Portfolio Properties5
726686688689703702700697700758774
Operating Properties
696657656
Development & Redevelopment Properties
302932
Outpatient Medical Properties2
506501504509530529527524527585594294
Outpatient Medical — Operating Properties
495492495500524522521519520579589294
Outpatient Medical — Development & Redevelopment
1199
Lab (Life Science) Properties2
143141141146139139139139139139146131
Lab — Operating Properties
124121118124115113109111118120125131
Lab — Development & Redevelopment
192023
Senior Housing Communities
744140151515151515151515
Outpatient Medical — Total Rentable Capacity(nghìn ft²)6
35,914.035,758.036,100.037,019.037,784.037,791.037,030.037,048.037,043.039,702.040,131.0
Operating Rentable Square Feet(nghìn ft²)
34,984.034,958.035,300.036,477.037,268.037,105.037,030.037,048.037,043.039,702.040,131.0
Occupied Square Feet(nghìn ft²)
32,414.032,330.032,415.0
Same-Store Pool Square Feet(nghìn ft²)
34,046.034,039.034,037.034,039.034,037.034,149.07,896.035,160.036,399.036,317.036,316.036,532.0
Development & Redevelopment Capacity(nghìn ft²)
930.0800.0800.0
Fee-Simple Owned Square Feet(nghìn ft²)
15,599.015,476.018,487.0
Hospital Ground-Leased Square Feet(nghìn ft²)
20,315.020,282.017,614.0
Lab — Total Rentable Capacity(nghìn ft²)5
12,617.012,387.012,373.012,835.011,480.011,462.09,653.09,716.09,974.010,031.010,516.010,959.0
Operating Rentable Square Feet(nghìn ft²)
10,650.010,228.09,807.011,406.010,004.09,762.09,653.09,716.09,974.010,031.010,516.0
Occupied Square Feet(nghìn ft²)
9,829.09,604.09,507.0
Same-Store Pool Square Feet(nghìn ft²)
7,963.07,969.07,956.07,956.07,956.07,846.07,896.07,953.08,101.0
Development & Redevelopment Capacity(nghìn ft²)
1,966.02,159.02,566.0
Fee-Simple Owned Square Feet(nghìn ft²)
12,617.012,387.012,373.0
Senior Housing — Total Portfolio Units1
15,25611,42011,2527,0677,0677,0657,0647,0607,0607,0617,088
Same-Store Senior Housing Units
7,0297,0677,0697,0677,0677,0657,0647,0607,0607,0617,0887,085
Outpatient Medical — Portfolio Occupancy Rate(%)5
90.3%90.7%90.5%90.6%90.6%90.5%92.2%92.2%92.2%92.1%92.0%
Same-Store Occupancy Rate(%)
91.7%91.6%91.6%91.8%91.7%92.4%97.8%92.6%92.5%92.7%92.5%92.3%
Fee-Simple Ownership Share of Sq. Ft.(%)
43.4%43.3%51.2%
Weighted Average Remaining Lease Term (WALT)
66.0065.0066.00
Average Annual Contractual Rent Escalator(%)
2.8%2.8%2.7%
Fixed Contractual Escalator Share of Leases(%)
95.8%95.8%95.6%
Lab — Portfolio Occupancy Rate(%)6
79.8%78.5%77.7%77.1%81.0%82.2%83.7%97.5%95.7%95.4%96.0%96.9%
Same-Store Occupancy Rate(%)
90.6%90.4%90.1%89.9%92.7%94.4%97.8%97.8%97.7%
Triple-Net (NNN) Lease Share of Occupied Sq. Ft.(%)
89.8%90.1%89.7%
Fee-Simple Ownership Share of Sq. Ft.(%)
100.0%100.0%100.0%
Weighted Average Remaining Lease Term (WALT)
67.0068.0068.00
Average Annual Contractual Rent Escalator(%)
3.2%3.2%3.2%
Fixed Contractual Escalator Share of Leases(%)
100.0%100.0%100.0%
Senior Housing — Portfolio Occupancy Rate(%)1
86.5%85.5%86.1%87.4%86.7%86.0%86.2%85.8%85.2%85.4%85.2%
Same-Store Occupancy Rate(%)
89.7%88.6%88.5%87.4%86.7%86.0%86.2%85.8%85.2%85.4%85.2%84.9%
Outpatient Medical — Renewal Cash Releasing Spread(%)5
4.5%4.9%5.4%4.4%5.4%5.9%4.1%6.8%7.8%4.0%3.4%3.6%
Trailing 12-Month Tenant Retention Rate(%)
81.7%80.1%79.1%78.5%76.2%84.8%85.5%88.2%88.8%83.2%84.1%
Executed Lease Volume (Signed)(nghìn ft²)2
846.01,243.01,063.01,738.01,165.01,035.0
New Lease Share of Executions(%)
26.0%26.0%18.0%17.0%23.0%18.0%
Renewal Share of Executions(%)
74.0%74.0%82.0%83.0%77.0%82.0%
New Lease Commencements(nghìn ft²)5
362.0252.0199.0299.0348.0308.0232.0807.0594.0376.0120.0212.0
New Lease Annualized Base Rent per Sq. Ft.($)
32.4127.2426.8329.1628.1328.9426.8627.9928.2229.1929.9428.61
New Lease Average Term
135.0094.0087.0084.00107.00116.0087.0094.0098.0096.0080.00
New Lease Tenant Improvements per Sq. Ft. / Yr($)
4.204.514.143.864.473.34
New Lease Commissions per Sq. Ft. / Yr($)
1.481.301.581.291.311.25
New Lease Costs % of Annual Base Rent(%)
17.5%21.3%21.3%17.7%20.5%15.9%
Renewal Commencements — Annualized Base Rent per Sq. Ft.($)3
27.3531.3628.5129.8028.7931.8230.4327.0826.5928.3328.2429.34
Renewal Average Lease Term
82.0065.0074.00105.0063.0071.0068.0081.0083.0076.0090.00
Renewal Tenant Improvements per Sq. Ft. / Yr($)
1.841.831.441.611.412.15
Renewal Commissions per Sq. Ft. / Yr($)
0.761.260.540.710.601.10
Non-Renewals & Tenant Vacates(nghìn ft²)
298.0202.0288.0235.0474.0370.0
Lab — Renewal Cash Releasing Spread(%)5
-5.6%-7.3%3.5%-1.7%4.6%6.1%4.7%11.4%6.7%5.8%2.6%-7.6%
Trailing 12-Month Tenant Retention Rate(%)
55.7%50.5%69.0%71.6%83.0%86.5%88.2%78.2%71.6%73.2%21.6%
Executed Lease Volume (Signed)(nghìn ft²)2
480.0381.0141.0333.0339.0486.0
New Lease Share of Executions(%)
70.0%58.0%92.0%78.0%45.0%13.0%
Renewal Share of Executions(%)
30.0%42.0%8.0%22.0%55.0%87.0%
New Lease Commencements(nghìn ft²)5
276.0303.049.0317.0362.0230.0149.0904.0817.0576.0312.019.0
New Lease Annualized Base Rent per Sq. Ft.($)
44.2858.1456.2656.4868.6151.5359.6366.4166.0571.6370.5280.85
New Lease Average Term
115.00110.0057.0071.00114.0094.0058.00100.0099.00106.00117.00
New Lease Tenant Improvements per Sq. Ft. / Yr($)
13.5018.934.4111.9615.7313.34
New Lease Commissions per Sq. Ft. / Yr($)
2.633.303.313.253.182.69
New Lease Costs % of Annual Base Rent(%)
36.4%38.2%13.7%26.9%27.6%31.1%
Renewal Commencements — Annualized Base Rent per Sq. Ft.($)3
72.2246.4870.7040.3565.0552.9741.3455.1754.0552.0557.4457.35
Renewal Average Lease Term
37.00115.0012.0084.0041.0062.0028.0084.0091.0096.0023.00
Renewal Tenant Improvements per Sq. Ft. / Yr($)
4.793.0500.111.303.42
Renewal Commissions per Sq. Ft. / Yr($)
2.832.4643.312.272.02
Non-Renewals & Tenant Vacates(nghìn ft²)
126.0206.014.0587.0318.0366.0
Total Portfolio — Same-Store Cash NOI YoY Growth(%)6
3.6%1.8%0.0%3.9%3.5%7.0%5.4%4.5%
Outpatient Medical — Same-Store Cash NOI YoY Growth(%)
3.1%2.5%2.4%4.1%2.0%1.5%5.0%3.4%3.1%4.3%
Lab — Same-Store Cash NOI YoY Growth(%)
-0.7%-3.2%-7.2%-0.3%-3.2%
Senior Housing — Same-Store Cash NOI YoY Growth(%)
25.9%19.2%13.8%16.7%9.4%8.6%22.3%20.5%4.7%
Outpatient Medical — Same-Store Cash Revenue YoY Growth(%)
1.9%3.2%3.3%4.1%4.0%2.9%4.1%4.4%
Lab — Same-Store Cash Revenue YoY Growth(%)
0.5%-2.1%-3.7%-2.7%
Senior Housing — Same-Store Cash Revenue YoY Growth(%)
9.8%8.4%7.6%5.3%5.7%7.3%7.0%
Total Portfolio — Same-Store Cash (Adjusted) NOI($M)6
319319315319308329336340350343337333
Total Same-Store Pool Properties
600600600600600600599634639696714
Total Same-Store Cash Real Estate Revenues($M)
544536534537528550564596605593585579
Total Same-Store Cash Operating Expenses($M)
226217219218221220229256259250248246
Outpatient Medical — Same-Store Cash NOI($M)3
173173171171168184122184192120187187
Outpatient Medical Same-Store Properties
482482482482482484101486514513106107
Outpatient Medical Same-Store Cash Revenues($M)
264261261260259276284281289286284165
Outpatient Medical Same-Store Cash Expenses($M)
91.087.989.589.591.291.446.297.397.697.096.494.2
Lab — Same-Store Cash NOI($M)3
114115114119114118122120120123123121
Lab Same-Store Properties
103103103103103101101102102111111111
Lab Same-Store Cash Revenues($M)
1661631621701651651711711730.10
Lab Same-Store Cash Expenses($M)
52.247.348.650.250.646.646.248.852.650.749.852.9
Senior Housing — Same-Store Cash NOI($M)3
31.930.230.529.225.326.931.636.233.834.033.729.7
Senior Housing Same-Store Communities
151515151515151515151515
Senior Housing Same-Store Cash Revenues($M)
114112111108104110122149143141139136
Senior Housing Same-Store Cash Expenses($M)
82.581.480.578.678.882.690.0110109107105106
Total Portfolio — Segment Adjusted (Cash) NOI($M)5
381389398392381387
Outpatient Medical — Total Adjusted NOI($M)
184198198204200202
Lab — Total Adjusted NOI($M)
141143141140138143146
Senior Housing — Total Adjusted NOI($M)
53.745.955.441.936.636.6
Other Non-Reportable — Total Adjusted NOI($M)
2.522.923.125.365.625.98
Total Portfolio — GAAP Net Operating Income (NOI)($M)3
403410418426407411
Outpatient Medical — GAAP NOI($M)
1932072092152112120.09
Lab — GAAP NOI($M)
1551551501621541551610.08
Senior Housing — GAAP NOI($M)
53.245.955.443.536.637.438.70.10
Full-Year 2026 Guidance — Diluted FFO as Adjusted per Share (High)($)13
1.781.771.75
Diluted FFO as Adjusted per Share Guidance (Low)($)
1.761.731.71
Diluted GAAP EPS Guidance (Low)($)
0.390.480.46
Diluted GAAP EPS Guidance (High)($)
0.410.520.50
Total Same-Store Cash NOI Growth Guidance (Low)(%)
0.5%0.0%-1.0%
Total Same-Store Cash NOI Growth Guidance (High)(%)
2.0%1.5%-1.0%
Outpatient Medical SS Cash NOI Growth Guidance (Low)(%)
2.5%2.0%2.0%
Outpatient Medical SS Cash NOI Growth Guidance (High)(%)
3.0%3.0%3.0%
Lab SS Cash NOI Growth Guidance (Low)(%)
-6.0%-7.0%-10.0%
Lab SS Cash NOI Growth Guidance (High)(%)
-3.0%-4.0%-5.0%
Senior Housing SS Cash NOI Growth Guidance (Low)(%)
16.0%13.0%11.0%
Senior Housing SS Cash NOI Growth Guidance (High)(%)
19.0%17.0%15.0%
Acquisitions & Share Repurchases Guidance($M)
1,2001,0001,000
Dev/Redev & Revenue-Enhancing CapEx Guidance($M)
400400400
San Francisco Bay Area, CA — Quarterly Cash NOI($M)3
93.394.794.388.5
San Francisco Bay Area, CA — % of Portfolio Cash NOI(%)
23.7%23.7%23.3%23.0%
Boston, MA — Quarterly Cash NOI($M)1
33.635.034.735.435.939.337.52.692.692.71
Boston, MA — % of Portfolio Cash NOI(%)
8.6%8.8%8.6%9.0%9.0%10.0%10.0%10.0%10.0%10.0%
Dallas, TX — Quarterly Cash NOI($M)1
25.128.428.029.728.23027.84.244.244.25
Dallas, TX — % of Portfolio Cash NOI(%)
6.4%7.1%6.9%8.0%7.0%8.0%7.0%9.0%8.0%7.0%
Health Systems — Annualized Base Rent($M)8
541593587
Health Systems — % of Portfolio ABR & NOI(%)
31.6%34.5%34.4%
Large-Cap Biopharma (>$10B Market Cap) — Annualized Base Rent / NOI($M)1
241226219
Large-Cap Biopharma (>$10B Market Cap) — % Share(%)
14.0%13.2%12.8%
Senior Housing (Annualized Adjusted NOI) — Annualized Base Rent / NOI($M)1
262222222
Senior Housing (Annualized Adjusted NOI) — % Share(%)
15.3%12.9%13.0%
Physician Group Practices — Annualized Base Rent / NOI($M)1
207216218
Physician Group Practices — % Share(%)
12.1%12.5%12.7%
Medical Device, R&D, University & Other — Annualized Base Rent / NOI($M)1
149144147
Medical Device, R&D, University & Other — % Share(%)
8.7%8.4%8.6%
Mid-Cap Biopharma ($500M–$10B Market Cap) — Annualized Base Rent / NOI($M)1
127120125
Mid-Cap Biopharma ($500M–$10B Market Cap) — % Share(%)
7.4%7.0%7.3%
Private Biopharma — Annualized Base Rent / NOI($M)1
105119110
Private Biopharma — % Share(%)
6.2%6.9%6.4%
Small-Cap Biopharma (<$500M Market Cap) — Annualized Base Rent / NOI($M)1
81.179.681.7
Small-Cap Biopharma (<$500M Market Cap) — % Share(%)
4.7%4.6%4.8%
Top 20 Tenants Combined — Share of Portfolio Annualized Base Rent(%)13
34.7%34.6%34.5%
Top 20 Tenants — Combined Leased Area(nghìn ft²)
14,292.016,066.014,738.0
HCA Healthcare — % of Annualized Base Rent(%)1
10.9%10.4%10.4%
HCA Healthcare — Leased Area(nghìn ft²)
5,251.05,225.05,198.0
CommonSpirit Health (Health System) — % of Annualized Base Rent(%)
2.4%2.5%2.4%
McKesson Corporation (Health System) — % of Annualized Base Rent(%)
1.2%1.4%1.5%
Roche Holding AG (Large-Cap Biopharma) — % of Annualized Base Rent(%)
1.5%1.5%1.4%
Bristol-Myers Squibb (Large-Cap Biopharma) — % of Annualized Base Rent(%)
1.5%1.5%1.5%
Northside Hospital (Health System) — % of Annualized Base Rent(%)
1.5%1.4%1.4%
Revolution Medicines (Large-Cap Biopharma) — % of Annualized Base Rent(%)
1.5%1.4%1.4%
Ascension Health (Health System) — % of Annualized Base Rent(%)
1.0%1.2%1.3%
Novo Nordisk (Large-Cap Biopharma) — % of Annualized Base Rent(%)
1.3%1.2%1.2%
University of Louisville (Health System) — % of Annualized Base Rent(%)
1.4%1.5%1.2%
Johnson & Johnson (Large-Cap Biopharma) — % of Annualized Base Rent(%)
1.2%1.2%1.2%
Pfizer (Large-Cap Biopharma) — % of Annualized Base Rent(%)
1.0%0.9%1.0%
Diluted FFO as Adjusted Applicable to Common Shares($M)7
309325317332323326330329321320277253
Diluted FFO as Adjusted per Common Share($)
0.440.460.450.470.460.460.460.460.450.450.450.46
FFO as Adjusted (Basic)($M)
305321312327319321325325316316275250
Diluted Nareit FFO($M)
301323302333323308323311316319162264
Diluted Nareit FFO per Common Share($)
0.430.460.420.470.450.430.450.440.440.440.270.48
Weighted Average Diluted Shares (FFO)(M)
704704709709710710714715715718611555
General & Administrative Expense — Healthpeak($M)
18.318.721.323.619.920.8
General & Administrative Expense — Janus Living($M)
5.313.813.29
Total Capital Expenditures (Portfolio at Share)($M)10
174156121244
AFFO Capital Expenditures (Recurring + 2nd-Gen TI/LC)($M)
37.642.124.057.827.325.723.139.023.535.717.547.3
Recurring Capital Expenditures($M)
13.611.88.1528.0
Tenant Improvements & Leasing Commissions($M)
20.526.117.6
Revenue-Enhancing Capital Expenditures($M)
65.046.816.547.5
Development Capital Expenditures($M)
24.520.32.1340.2
Redevelopment Capital Expenditures($M)
27.529.834.834.8
Capitalized Interest($M)
17.719.619
Outpatient Medical Segment CapEx($M)
77.657.449.5112
Lab Segment CapEx($M)
77.379.960.984.8
Senior Housing Segment CapEx($M)
17.518.110.742.8
Active Development & Redevelopment Pipeline — Estimated Total Cost($M)2
684750891
Estimated Cost to Complete($M)
275303352
Projected Stabilized Portfolio Adjusted NOI($M)
717883
Net Debt to Adjusted EBITDAre(×)16
4.704.705.405.205.305.205.205.205.105.205.205.20
Adjusted EBITDAre (Quarterly)($M)
473455433454428438428414411418
Annualized Adjusted EBITDAre($M)
1,8911,8221,7341,8141,7141,752
Adjusted Fixed Charge Coverage Ratio(×)
4.404.003.904.304.204.404.40
Financial Leverage Ratio (Enterprise Debt / Gross Assets)(%)
34.2%37.8%39.0%38.5%36.9%36.4%35.9%
Secured Debt Ratio(%)
1.2%1.2%1.7%2.1%2.2%2.2%2.1%
Enterprise Debt (Pro Rata Share)($M)
9,60410,24410,63510,0589,3329,2419,062
Enterprise Gross Assets($M)
28,05627,12127,25426,15025,26625,370
Total Available Liquidity($M)
4,1754,1313,4202,3892,7232,314
Credit Facilities Capacity & Term Loans($M)
5,1504,0004,0003,0003,0003,0003,000
Commercial Paper Balance Outstanding($M)
1,4901,4961,7511,079368775164
Total Floating-Rate Debt($M)
1,6081,6121,8671,193542888
Floating-Rate Share of Enterprise Debt(%)
16.5%15.6%17.4%11.7%5.7%9.5%2.9%
Weighted Average Interest Rate (GAAP)(%)
4.3%4.2%4.2%4.2%4.3%4.3%4.2%
Weighted Average Coupon Rate(%)
3.9%3.9%3.9%3.9%3.9%3.9%3.9%
Quarterly Cash Dividends Declared per Common Share($)
0.310.310.310.310.310.310.31
Market Value of Healthpeak's 214.7M Shares/Units in Janus Living($M)
6,3636,3455,652
Janus Living (NYSE: JAN) — Total Senior Housing Communities2
74414034343434
Same-Store Pool Communities
15151515151515
Life Care Services (LCS) Operated Communities3
151515
LCS Share of Janus Living Adjusted NOI(%)
56.6%69.6%65.8%
Sunrise Senior Living Operated Communities
222
Sunrise Share of Janus Living Adjusted NOI(%)
8.7%11.0%12.6%
Janus Living — Total Portfolio Occupancy Rate1
Same-Store Total Occupancy Rate3
Same-Store Independent Living Occupancy Rate(%)
89.4%88.5%88.0%86.9%86.1%85.0%84.7%
Same-Store Assisted Living & Memory Care Occupancy Rate(%)
92.3%91.5%91.5%91.1%90.1%89.5%89.3%
Same-Store Skilled Nursing Occupancy Rate(%)
88.0%85.6%87.4%85.4%85.7%86.4%89.1%
Janus Living — Same-Store Monthly RevPOR (Incl. NREF Amortization)1
Total Portfolio NREF Cash Collections($M)3
46.540.735.044.536.942.7
Total Portfolio GAAP NREF Amortization($M)
29.827.827.227.124.223.7
Same-Store NREF Cash Collections($M)
46.240.535.044.536.942.728.7
Same-Store GAAP NREF Amortization($M)
29.227.827.227.124.223.724.0
Janus Living — Total Portfolio Cash (Adjusted) NOI($M)4
75.657.756.547.241.842.244.4
Total Portfolio Cash NOI Margin(%)
28.2%26.6%27.8%26.6%24.2%24.6%25.9%
Total Resident Fees & Services Cash Revenue (Excl. NREF)($M)
268216203178173171171
Total Portfolio Labor Expense($M)
10990.684.176.075.074.273.6
Same-Store Cash (Adjusted) NOI($M)3
46.143.744.042.236.636.6
Same-Store Cash NOI Margin(%)
27.9%27.1%27.5%27.1%24.3%24.6%26.0%
Same-Store Resident Fees & Services Revenue($M)
165161160156150149149
Same-Store Labor Expense($M)
68.867.967.766.965.965.264.6
Janus Living — Standalone Diluted FFO as Adjusted($M)20
75.964.049.941.036.836.2
Standalone Diluted FFO as Adjusted per Share($)
0.250.240.230.190.170.17
Standalone Diluted Nareit FFO($M)
73.165.633.637.133.435.4
Standalone Diluted Nareit FFO per Share($)
0.240.240.150.170.160.16
Standalone Adjusted EBITDAre($M)
10579.565.263.052.259.5
Standalone GAAP Net Income (Loss)($M)
-5.6114.927.99.621.41-2.57
Related-Party Management Fee Paid to Healthpeak($M)
3.782.470.33
Standalone Direct General & Administrative Expense($M)
1.531.332.962.772.272.383.13
Standalone AFFO Capital Expenditures($M)
7.165.283.4011.65.763.280.29
Standalone Revenue-Enhancing Capital Expenditures($M)
15.716.96.4722.014.012.95.59
Standalone Operating Cash Flow($M)
11279.633.342.823.749.520.8
Standalone Net Real Estate Investments($M)
4,0972,5942,5211,6541,605
Standalone Total Assets($M)
5,2204,7104,0242,3422,343
Standalone Cash & Cash Equivalents($M)
3381,55894919.719.522.6
Standalone Available Liquidity($M)
1,5882,1581,54919.719.422.621.2
Janus Living Total Enterprise Value($M)
9,1948,3896,202
Janus Living Period-End Share Price($)
29.6328.7423.57
Janus Living FY 2026 FFO as Adjusted / Share Guidance (Low)($)
0.970.950.93
Janus Living FY 2026 FFO as Adjusted / Share Guidance (High)($)
0.990.980.97
Janus Living FY 2026 SS Cash NOI Growth Guidance (Low)(%)
16.0%13.0%11.0%
Janus Living FY 2026 SS Cash NOI Growth Guidance (High)(%)
19.0%17.0%-15.0%
Alexandria Real Estate Equities, Inc. (ARE) — Total Revenues($M)3
642630642714724724732750765746747734
Alexandria Real Estate Equities, Inc. (ARE) — Net Real Estate Investments($M)
28,42729,12628,83028,69031,74432,16132,12232,11032,95232,67432,32331,634
Alexandria Real Estate Equities, Inc. (ARE) — Operating Cash Flow($M)
342337197312434460208274477412341429
Alexandria Real Estate Equities, Inc. (ARE) — Total Assets($M)
34,05234,63234,16734,08237,37537,62437,60037,52738,48837,84837,69936,771
Healthcare Realty Trust Incorporated (HR) — Total Revenues($M)3
287282279286298298299310315316327330
Healthcare Realty Trust Incorporated (HR) — Net Real Estate Investments($M)
7,6137,7457,8207,8958,0108,6759,2119,3279,89810,43511,03511,172
Healthcare Realty Trust Incorporated (HR) — Operating Cash Flow($M)
12214252.913211416347.813811916876.2127
Healthcare Realty Trust Incorporated (HR) — Total Assets($M)
8,9609,0019,1489,2119,86010,23610,49610,65111,24511,80412,28112,637
Welltower Inc. (WELL) — Total Revenues($M)3
3,7163,5453,3523,1812,6862,5482,4232,2512,0561,8251,8601,750
Welltower Inc. (WELL) — Net Real Estate Investments($M)
61,24558,05453,15553,42345,32844,30143,08340,67339,20037,21936,98337,063
Welltower Inc. (WELL) — Operating Cash Flow($M)
1,0031,004670654858770599559685605407371
Welltower Inc. (WELL) — Total Assets($M)
73,71169,87567,22167,30359,50555,83453,29451,04448,95445,53444,55444,012
Ventas, Inc. (VTR) — Total Revenues($M)2
1,8321,7301,6571,5661,4891,4211,3581,2871,2361,2011,2001,164
Ventas, Inc. (VTR) — Operating Cash Flow($M)
490557395472379475321374354336266279
Ventas, Inc. (VTR) — Total Assets($M)
30,62529,65627,68727,59226,92626,47526,03226,18725,34724,53024,67324,725
Omega Healthcare Investors, Inc. (OHI) — Total Revenues($M)3
341328323319312283277279276253243239
Omega Healthcare Investors, Inc. (OHI) — Net Real Estate Investments($M)
6,5656,4686,4706,7036,7426,7956,3336,3396,2925,8775,8345,903
Omega Healthcare Investors, Inc. (OHI) — Operating Cash Flow($M)
191218216231227239182229185184152165
Omega Healthcare Investors, Inc. (OHI) — Total Assets($M)
10,12110,01510,23510,04910,59610,5479,7069,8989,5728,8499,0129,117
U.S. Healthcare Construction Spending (SAAR)1
U.S. Vacant Housing Units for Rent (Census HVS)
3,866.003,727.003,674.003,561.003,547.003,546.003,533.003,393.003,409.003,241.003,184.003,220.00
Total Consolidated Revenues (GAAP)($M)6
821772753719706694703698700696607554
Total Costs and Expenses($M)
795739747661653652643668665666666496
General and Administrative Expense (Consolidated)($M)
23.622.524.623.619.920.826.123.923.226.723.321.6
Interest Expense($M)
83.992.387.380.676.875.172.770.574.174.960.952.8
Depreciation and Amortization($M)
299283290262262266269275280284219189
Net Income Attributable to Common Stockholders($M)
17.152.7194114-11731.642.44.4085.71466.5070.8
Diluted Earnings per Common Share (GAAP)($)
0.020.080.280.16-0.170.050.0600.120.210.010.13
Total Consolidated Assets($M)5
22,41221,68021,61620,33619,58219,81019,81619,93819,97020,18020,54215,699
Net Real Estate Investments($M)
18,48916,86416,83716,09915,83115,82015,84015,83115,89216,39816,66313,028
Cash and Cash Equivalents($M)
5141,6271,1714689189.470.6120180107102118
Total Liabilities($M)
11,60712,18212,55612,03411,31711,22310,97210,88110,74810,76110,9438,774
Healthpeak Stockholders' Equity($M)
7,8667,8457,8267,5007,5977,9288,1888,4018,5638,7588,8826,350
Noncontrolling Interests (Incl. Janus Living Public Float & JVs)($M)
2,9121,6261,207643640639641654658660663526
Net Cash Provided by Operating Activities($M)4
355361261294315364279284318316153231
Net Cash Used in Investing Activities($M)
-2,073133-639-406-188-210-231-23430.2188-97.8-216
Net Cash Provided by (Used in) Financing Activities($M)
606-411,106490-130-129-94.4-108-266-502-66.639.5
Cash Dividends Paid on Common Stock($M)
210210212212212212214210210211164164
Common Stock Repurchases($M)
0.101001.400.10072.1250.3020.168.21020

37 chỉ số không có số liệu trong 12 quý gần nhất — .

In nghiêng là số StockData tự tính từ số đã báo cáo (rê chuột để xem công thức). Số có gạch chân chấm là số đọc từ câu chữ trong thông cáo kết quả và bản trình bày; rê chuột để xem đúng câu đó. Tick vào một dòng để thêm vào biểu đồ phía trên (tối đa 8 đường).

Phương pháp và các chỉ số bị loại
  • Các dòng ở Cốt lõi lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K và 10-Q (XBRL), có liên kết tới từng hồ sơ. Số quý 4 bằng cả năm tài chính trừ chín tháng đầu (hiện bằng chữ in nghiêng).
  • Fiscal year ends December 31; latest company-reported period is Q3 2026 (ended September 30, 2026, filed November 2–3, 2026).
  • On March 1, 2024, Healthpeak completed its all-stock merger with Physicians Realty Trust (NYSE: DOC) and changed its NYSE ticker symbol from PEAK to DOC, expanding the Outpatient Medical portfolio by nearly 300 properties.
  • In March 2026, Healthpeak completed the IPO of its senior housing portfolio as Janus Living, Inc. (NYSE: JAN); Healthpeak retained 214.7 million common shares and OP units (~74.5%–81% economic ownership during 2026) and continues to consolidate Janus Living under US GAAP.
  • Healthpeak operates under a US GAAP UPREIT structure without standalone parent operating financial statements; pro rata share metrics are reported directly in the Quarterly Supplemental Reports.

Không hiện vì thiếu các kỳ gần đây (5)

  • Adjusted Funds From Operations (AFFO) — Discontinued in Healthpeak's redesigned Q1 2026 Supplemental Report; AFFO Capital Expenditures and FFO as Adjusted continue to be reported.
  • Triple-Net Lease Operator EBITDARM Coverage — Discontinued following Healthpeak's 2020–2021 exit from triple-net senior housing and skilled nursing leases.
  • Scope 3 Value-Chain GHG Emissions (395,717 mtCO2e in FY2025) — Excluded from multi-year series due to methodology and category expansion in FY2025 lacking comparable restated FY2024 figures.
  • New Janus Living Operators Added in Q2–Q3 2026 (Pegasus, Ciel, Holbrook, Cedarhurst) — Excluded until three consecutive quarters of standalone history accumulate.
  • Narrative Approximate Figures (e.g., 'approximately $25 billion portfolio', 'more than 40 years', 'less than 1%') — Excluded because approximate bounds are not exact point disclosures.

Dữ liệu cập nhật 2026-11-14.

Mỗi KPI một trang riêng

Đầy đủ lịch sử, biểu đồ, nguồn và cách trích dẫn cho từng chỉ số

Tài liệu nguồn mới nhất

Các tài liệu được trích nhiều nhất cho số liệu mới nhất của Healthpeak Properties

See a number that looks wrong?